Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T
The effects are continuous, which is why our guidance aims to be specific and strategic
Figure 3: Kaplan-Meier Curves for Overall Survival in Non-squamous NSCLC in Study JMDB Maintenance Treatment Following First-line Non-Pemetrexed Containing Platinum-Based Chemotherapy The efficacy of pemetrexed as maintenance therapy following first-line platinum-based chemotherapy was evaluated in Study JMEN (NCT00102804), a multicenter, randomized (2:1), double-blind, placebo-controlled study conducted in 663 patients with Stage IIIb/IV NSCLC who did not progress after four cycles of platinum-based chemotherapy
documented research protocols reference about 100 mcg per dose
DoDI 6130.06 provides guidelines to establish an official list of prohibited substances, over and above anabolic steroids as contained in Schedule III
At higher doses,glutamine is a powerful anti-oxidant as well